Pacific Biosciences (PACB) Partners with UW Medicine and Seattle Children's to Advance Childhood Death Research with HiFi Genome Sequencing

Pacific Biosciences (PACB) collaborates with UW Medicine and Seattle Children's on a research project to explore Sudden Unexplained Death in Childhood using its HiFi whole-genome sequencing technology. Despite innovative projects, the company faces financial challenges with negative margins, declining revenue growth, and a distress Z-Score. Investors should consider Pacific Biosciences' poor financial health, sector-specific risks, and high volatility before investing.